Amica Mutual Insurance’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-35,364
Closed -$106K 326
2019
Q4
$106K Buy
+35,364
New +$92K 0.01% 314

Other funds holding BMY.RT

Amica Mutual Insurance's BMY.RT Position: Q1 2020 in Review

Amica Mutual Insurance sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2020, closing a stake of 35,364 shares — an estimated $106K sold.

Amica Mutual Insurance first reported a position in BMY.RT in Q4 2019 and held it in 1 quarter. The position peaked at $106K in Q4 2019. 581 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2020.

  • Amica Mutual Insurance reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
  • Amica Mutual Insurance sold 35,364 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2020, an estimated $106K.
  • Amica Mutual Insurance first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 1 quarter.
  • Amica Mutual Insurance's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $106K in Q4 2019.
  • 581 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2020.

Based on Amica Mutual Insurance's 13F filing for Q1 2020, filed 13 May 2020.